Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal microenvironment pH is a critical physiological parameter that defines the health and defensive capacity of the female reproductive tract. In healthy individuals of reproductive age, the pH is typically maintained in an acidic range between 3.8 and 4.5, primarily through the production of lactic acid by commensal Lactobacillus species (StatPearls, 2023). This acidic environment serves as a potent biological barrier, inhibiting the growth of opportunistic pathogens such as Gardnerella vaginalis and reducing the transmission of sexually transmitted infections like HIV and HSV-2 (PubMed, 2021). Disruptions in this balance, leading to an increase in pH, are associated with dysbiosis, most notably bacterial vaginosis, and can occur due to factors like menses, semen, or antibiotic use (NIH, 2022). Therapeutic targeting of the vaginal pH involves the application of acidifying agents or buffering systems to restore the natural acidic balance. For instance, products containing lactic acid, citric acid, and potassium bitartrate are utilized both for maintaining vaginal health and as non-hormonal contraceptives, as the acidic environment effectively immobilizes sperm (FDA, 2020). Additionally, boric acid is frequently employed as an antiseptic and acidifying agent for recurrent infections. Monitoring vaginal pH serves as a key diagnostic biomarker for identifying dysbiosis and evaluating the efficacy of intravaginal treatments.
Direct acidification and buffering of the vaginal lumen to maintain a protective pH range (3.5–4.5), which inhibits the growth of pathogenic anaerobes and immobilizes spermatozoa.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal microenvironment pH (pH).